Δείτε φωτογραφίες από τις προηγούμενες διοργανώσεις του συνεδρίου HTA Conference και κατεβάστε τις παρουσιάσεις.
HTA Conference 2023
HTA: Setting goals for an innovative future
The right drug to the right patient, at the right time, at the right price.
With the participation of 30 distinguished Greek and foreign speakers and more than 250 participants, including health professionals, researchers, academics, policy makers, industry representatives and patients, the largest annual conference on the Evaluation of Health Technologies (HTA) in Greece, organized by Health Daily and BOUSSIAS EVENTS, was concluded successfully. The 8th HTA conference, under the specific title: Setting goals for an innovative future, took place on June 14, 2023 in Athens at the DIVANI CARAVEL Ηotel.
The main theme of the 2023 HTA conference was the new role that HTA and Negotiations are called upon to take on, in the context of new EU Regulation on Health Technology Assessment which will allow vital and innovative health technologies – such as innovative medicines, certain medical devices, medical equipment and prevention and treatment methods – to be more widely available.
Significant interventions were made by both institutions and industry and offered an opportunity to discuss in depth the strategies, procedures, skills and capabilities needed to address challenges and overcome potential barriers to access many new and innovative therapies. After 5 years of operation of the HTA Committee and the Medicines’ Price Negotiation Committee, it was the right time to take a look back and reference to their difficulties, challenges and achievements as well as to assess the impact of these reforms on Greece’s pharmaceutical policy, setting goals towards an innovative future.
The conference was held under the auspices of the Panhellenic Pharmaceutical Industry Union (PEF), the Hellenic Market Access Union (ELEMA), the Hellenic Association of Pharmaceutical Companies (SFEE) and the PhRMA Innovation Forum (PIF).
The role of HTA in the era of radical changes & disruptive innovation
With the participation of more than 400 delegates, the largest annual conference on the Evaluation of Health Technologies (HTA) in Greece was concluded. The 6th conference, under the specific title: The role of HTA in the era of radical change & disruptive innovation, was organized by Health Daily and BOUSSIAS. President of the conference’s scientific committee was Prof. Panos Kanavos, Deputy Director, LSE Health, Department of Social Policy, London School of Economics.
Significant interventions were made by both institutions and industry, on the new role that the HTA and Negotiation Committee are called upon to play in Greece, particularly with new innovative and specialised treatments. The dilemma of the cost vs value of the Health service’s quality is the greatest challenge of the Health technologies’ assessment today according to the Secretary General of Health Services, Mr. Ioannis Kotsiopoulos, who opened the conference, while pharmaceutical companies will have to document the comparative benefit of integrating new therapies, inevitably setting stricter criteria in evaluation and negotiation. The need to staff the committees with specialized human resources was stressed by the representatives of the pharmaceutical industry and at the same time presented a series of proposals to improve processes and accelerate patient access. Important work was presented by the heads of the HTA and Negotiation Committees, Mrs. Bakopoulou and Mr. Philippou respectively, with an impressive performance in the number of medicines evaluated and reached a negotiated agreement.